文献速递衰弱、肌少症与跌倒老年慢病共病管理

疼痛患者肌少症患病率及两者相关性:系统综述与荟萃分析

Prevalence of Sarcopenia in Pain Patients and Correlation Between the Two Conditions: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Am Med Dir Assoc · 2022-03-23

结果显示疼痛患者肌少症总体患病率为0.11(95%CI 0.07-0.15),疼痛者发生肌少症的风险显著高于无疼痛者(OR 1.35,95%CI 1.17-1.56)。

要点

  • 疼痛患者肌少症总体患病率为0.11(95%CI 0.07-0.15)。
  • 疼痛与肌少症独立相关,OR为1.35(95%CI 1.17-1.56)。
  • 继发性肌肉骨骼痛与腰痛者肌少症患病率及关联强度更高。

核心结论

  • 疼痛患者中肌少症患病率相对较高,疼痛与老年人肌少症显著相关。
  • 建议在疼痛患者中筛查肌少症,优化早期识别与管理。

研究设计与样本

  • 系统综述与荟萃分析,检索Cochrane CENTRAL、Embase、MEDLINE等数据库自建库至2021年2月的观察性研究,并于2021年12月31日更新检索。
  • 采用随机效应模型计算疼痛患者肌少症的合并患病率及其相关性,并按疼痛分类、疼痛部位和肌少症诊断标准进行亚组分析。
  • 异质性采用I2统计量描述。

主要发现

  • 疼痛患者肌少症总体患病率为0.11(95%CI 0.07-0.15,P<.001;I2=92.3%)。
  • 疼痛者发生肌少症的风险独立高于无疼痛者(OR 1.35;95%CI 1.17-1.56;P=.025;I2=51.1%)。
  • 继发性肌肉骨骼痛者肌少症患病率为12%,OR为1.45(95%CI 1.19-1.78)。
  • 腰痛者肌少症患病率为21%,OR为1.95(95%CI 1.22-3.12)。

关键数值与推荐

  • 肌少症患病率按各研究中肌少症且疼痛的患者数计算。
  • 疼痛与肌少症的关联以OR表示,合并OR为1.35(95%CI 1.17-1.56)。
  • 亚组按疼痛分类、疼痛部位及肌少症诊断标准划分。

临床怎么用

  • 对疼痛患者,尤其继发性肌肉骨骼痛和腰痛者,应关注肌少症筛查。
  • 临床实践中应优化疼痛患者肌少症的早期识别与管理。

局限性

  • 研究间异质性较高(总体患病率I2=92.3%)。
  • 纳入研究均为观察性研究,研究质量为中至高等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sarcopenia is a generalized and progressive skeletal muscle disorder and has been proven to be associated with many diseases; however, the correlation between sarcopenia and pain has not yet been systematically clarified. This review aimed to investigate the prevalence of sarcopenia in patients with pain and to ascertain whether pain is independently associated with sarcopenia. DESIGN: Systematic review and meta-analysis. SETTING AND PARTICIPANTS: A systematic literature search was performed from the Cochrane Central Register of Controlled Trials, Embase, MEDLINE and Epub Ahead of Print, In-Process, In-Data-Review, and Other Non-Indexed Citations, Daily and Versions for observational studies from inception until February 2021, and our search was updated on December 31, 2021. METHODS: Sarcopenia prevalence was calculated according to the corresponding number of patients with sarcopenia and pain. We performed meta-analyses with random effects models to calculate the pooled prevalence of sarcopenia in pain and its correlations. Subgroup analyses were also performed based on pain classification, pain location, and diagnostic criteria for sarcopenia. Heterogeneity between the studies was described using the I2 statistic. RESULTS: Fourteen observational studies (13,953 participants, 44% women, and mean age from 40.1 to 76.6 years) were included. Study quality was rated moderate to high. The overall sarcopenia prevalence in patients with pain was 0.11 (95% CI 0.07-0.15, P < .001; I2 = 92.3%). People with pain were independently associated with a higher risk of sarcopenia than those without pain [odds ratio (OR) 1.35; 95% CI 1.17-1.56; P = .025; I2 = 51.1%]. Subgroup analyses showed that the cumulative prevalence and effect measures of sarcopenia were increased when individuals suffered secondary musculoskeletal pain (Prevalence = 12%; OR 1.45; 95% CI 1.19-1.78) and low back pain (Prevalence = 21%; OR 1.95; 95% CI 1.22-3.12). CONCLUSIONS AND IMPLICATIONS: The prevalence of sarcopenia in patients with pain is relatively high, and pain is significantly associated with sarcopenia in older adults. Attention is needed to screen sarcopenia among patients with pain and optimize its early detection and management in clinical practice.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Lin T, Dai M, Xu P, et al. Prevalence of Sarcopenia in Pain Patients and Correlation Between the Two Conditions: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2022. PMID: 35339458. doi:10.1016/j.jamda.2022.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。